Organization & Developments: WuXi AppTec

Parents

*Built a 20-site global network serving 6,000 customers across the drug lifecycle.
*Global impact: A de facto backbone for biotech innovation worldwide, lowering cost and time-to-clinic for thousands of programs.
*Global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company that is pioneering a new model of open-access research
*The company covers the entire development cycle through five core operations, including its capabilities in small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing,
WuXi NextCODE (WXNC)